Literature DB >> 158231

Cardiomegaly and heart failure in a patient with prolactin-secreting pituitary tumour.

G Curtarelli, C Ferrari.   

Abstract

Unexplained cardiomegaly with cardiac failure was observed in a 42-year-old woman in whom a pituitary tumour had been treated by radiotherapy five years previously. She had been amenorrhoeic for 10 years. Thyroid and adrenal function was normal. Despite treatment with digitalis and diuretic, her cardiac disease progressed until she died suddenly at the age of 45. Hyperprolactinaemia was evident some weeks before death, her serum concentration of 68 ng/ml being well above both the reported normal range (2--20 ng/ml) and the concentrations in eight female controls being treated for severe cardiac failure (5--25 ng/ml). Although the association of these two disorders might merely represent coincidence, heart disease with similar features is common in acromegaly and does not correlate with plasma growth hormone concentration. Since prolactin is known to exert metabolic growth hormone-like effects in animals and in man, the possibility should be considered that prolactin hypersecretion might induce or maintain cardiac disease in some patients with pituitary tumours. A preliminary survey of 35 subjects with hyperprolactinaemia has shown five with raised blood pressure and four, two of whom were normotensive, with cardiomegaly on chest radiography.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 158231      PMCID: PMC471069          DOI: 10.1136/thx.34.3.328

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  18 in total

1.  Prolactin-stimulated production of somatomedin by rat liver.

Authors:  M J Francis; D J Hill
Journal:  Nature       Date:  1975-05-08       Impact factor: 49.962

2.  Acromegaly.

Authors:  G J HAMWI; T G SKILLMAN; K C TUFTS
Journal:  Am J Med       Date:  1960-10       Impact factor: 4.965

3.  Letter: Acromegaly and cardiovascular disease.

Authors:  R L Cavalieri
Journal:  Ann Intern Med       Date:  1975-03       Impact factor: 25.391

4.  Actions of growth hormone, prolactin and thyroxine on serum somatomedin-like activity and growth in hypopituitary dwarf mice.

Authors:  A T Holder; M Wallis
Journal:  J Endocrinol       Date:  1977-08       Impact factor: 4.286

5.  Mortality in acromegaly.

Authors:  A D Wright; D M Hill; C Lowy; T R Fraser
Journal:  Q J Med       Date:  1970-01

6.  Prolactin studies in "functionless" pituitary tumours.

Authors:  D F Child; S Nader; K Mashiter; M Kjeld; L Banks; T R Fraser
Journal:  Br Med J       Date:  1975-03-15

7.  Increased serum prolactin in diabetic ketoacidosis; correlation between serum sodium and serum prolacting concentration.

Authors:  K F Hanssen; P A Torjesen
Journal:  Acta Endocrinol (Copenh)       Date:  1977-06

8.  Human prolactin: measurement in plasma by in vitro bioassay.

Authors:  D L Kleinberg; A G Frantz
Journal:  J Clin Invest       Date:  1971-08       Impact factor: 14.808

9.  Prolactin concentrations in patients with acromegaly: clinical significance and response to surgery.

Authors:  S Franks; H S Jacobs; J D Nabarro
Journal:  Clin Endocrinol (Oxf)       Date:  1976-01       Impact factor: 3.478

10.  Prolactin: a diabetogenic hormone.

Authors:  R Landgraf; M M Landraf-Leurs; A Weissmann; R Hörl; K von Werder; P C Scriba
Journal:  Diabetologia       Date:  1977-04       Impact factor: 10.122

View more
  4 in total

1.  Hyperprolactinaemia and cardiac disorders.

Authors:  G Curtarelli; C Ferrari
Journal:  Br Med J       Date:  1979-11-10

2.  Peripartum cardiomyopathy in a patient with hyperprolactinaemia.

Authors:  G S Matharu; M H Oelbaum
Journal:  Postgrad Med J       Date:  1984-01       Impact factor: 2.401

Review 3.  From Bench to Bedside: Translating the Prolactin/Vasoinhibin Axis.

Authors:  Jakob Triebel; Maria Ludivina Robles-Osorio; Renata Garcia-Franco; Gonzalo Martínez de la Escalera; Carmen Clapp; Thomas Bertsch
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-11       Impact factor: 5.555

Review 4.  Peripartum cardiomyopathy: disease or syndrome?

Authors:  Lucia Baris; Jérôme Cornette; Mark R Johnson; Karen Sliwa; Jolien W Roos-Hesselink
Journal:  Heart       Date:  2019-02-12       Impact factor: 5.994

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.